Raymond Wu

Chris O’Brien Lifehouse

Papers

2

Total Citations

30

H-Index

2

About

Raymond Wu is a head and neck surgeon whose research focuses on optimizing functional outcomes in patients undergoing transoral robotic surgery (TORS) for oropharyngeal cancer. His key contributions center on swallowing and communication recovery, challenging conventional treatment paradigms by investigating when adjuvant radiotherapy can be safely avoided. In his highly cited 2021 study (25 citations), Wu systematically analyzed functional outcomes after TORS, highlighting the critical need for standardized instrumental swallow examinations to accurately assess post-surgical recovery. His 2022 cohort study (5 citations) further advanced the field by demonstrating that selective omission of primary site adjuvant radiotherapy may preserve swallowing function without compromising disease control. Wu’s work directly addresses the heterogeneity that has long plagued TORS research, providing evidence-based frameworks for de-escalating treatment intensity. His findings have significant implications for improving quality of life in oropharyngeal cancer survivors, offering a more nuanced approach to balancing oncologic safety with functional preservation. Through rigorous methodology and patient-centered outcomes, Wu is shaping the next generation of minimally invasive head and neck cancer care.

Research Focus

Key Achievements

2
H-Index
2
Papers
30
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Swallowing and communication outcomes following primary transoral robotic surgery
25 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 14
🏛 Institutions: Chris O’Brien Lifehouse

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago